Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic

Mona P. Potter, Howard Y Liu, Michael C. Monuteaux, Carly S. Henderson, Janet Wozniak, Timothy E. Wilens, Joseph Biederman

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: The aim of this study was to describe prescribing practices in the treatment of pediatric bipolar disorder in a university practice setting. Method: A retrospective chart review was performed on 53 youths diagnosed using Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), criteria with bipolar spectrum disorder under the active care of child psychiatrists practicing in a pediatric psychopharmacology specialty clinic. Current medications, doses, and related adverse events were recorded. Clinicians were asked to provide a target disorder (bipolar mania/mixed state, depression, attention deficit hyperactivity disorder [ADHD], or anxiety) for each medication to the best of their ability. The Clinical Global Impressions-Severity (CGI-S) scale was used to measure severity of each disorder before treatment and the Clinical Global Impressions-Improvement (CGI-I) was used to quantify the magnitude of improvement with treatment. Meaningful improvement of the disorder was defined by CGI-I score of 1 or 2. Results: The mean number of psychotropic medications per patient was 3.0± 1.6. A total of 68% of patients were treated for co-morbid disorders; 23% of patients were treated with monotherapy, primarily with second-generation antipsychotics. Mania improved in 80% of cases, mixed state improved in 57% of cases, ADHD improved in 56% of cases, anxiety improved in 61% of cases, and depression improved in 90% of cases. Conclusion: The management of pediatric bipolar disorder often requires multiple medications. For the treatment of mania/mixed states, clinicians prescribed second-generation antipsychotics more frequently than mood stabilizers, especially in the context of monotherapy. Co-morbidity was a frequent problem with moderate success obtained with combined pharmacotherapy approaches. Further psychosocial strategies to augment pharmacotherapy may improve outcome while reducing the medication burden in pediatric bipolar disorder.

Original languageEnglish (US)
Pages (from-to)529-538
Number of pages10
JournalJournal of Child and Adolescent Psychopharmacology
Volume19
Issue number5
DOIs
StatePublished - Oct 1 2009

Fingerprint

Bipolar Disorder
Pediatrics
Therapeutics
Attention Deficit Disorder with Hyperactivity
Diagnostic and Statistical Manual of Mental Disorders
Antipsychotic Agents
Anxiety
Depression
Drug Therapy
Psychopharmacology
Aptitude
Child Care
Psychiatry
Morbidity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. / Potter, Mona P.; Liu, Howard Y; Monuteaux, Michael C.; Henderson, Carly S.; Wozniak, Janet; Wilens, Timothy E.; Biederman, Joseph.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 19, No. 5, 01.10.2009, p. 529-538.

Research output: Contribution to journalArticle

Potter, Mona P. ; Liu, Howard Y ; Monuteaux, Michael C. ; Henderson, Carly S. ; Wozniak, Janet ; Wilens, Timothy E. ; Biederman, Joseph. / Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. In: Journal of Child and Adolescent Psychopharmacology. 2009 ; Vol. 19, No. 5. pp. 529-538.
@article{2dc84a18ff354f54a8c1c1040d4c5b64,
title = "Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic",
abstract = "Objective: The aim of this study was to describe prescribing practices in the treatment of pediatric bipolar disorder in a university practice setting. Method: A retrospective chart review was performed on 53 youths diagnosed using Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), criteria with bipolar spectrum disorder under the active care of child psychiatrists practicing in a pediatric psychopharmacology specialty clinic. Current medications, doses, and related adverse events were recorded. Clinicians were asked to provide a target disorder (bipolar mania/mixed state, depression, attention deficit hyperactivity disorder [ADHD], or anxiety) for each medication to the best of their ability. The Clinical Global Impressions-Severity (CGI-S) scale was used to measure severity of each disorder before treatment and the Clinical Global Impressions-Improvement (CGI-I) was used to quantify the magnitude of improvement with treatment. Meaningful improvement of the disorder was defined by CGI-I score of 1 or 2. Results: The mean number of psychotropic medications per patient was 3.0± 1.6. A total of 68{\%} of patients were treated for co-morbid disorders; 23{\%} of patients were treated with monotherapy, primarily with second-generation antipsychotics. Mania improved in 80{\%} of cases, mixed state improved in 57{\%} of cases, ADHD improved in 56{\%} of cases, anxiety improved in 61{\%} of cases, and depression improved in 90{\%} of cases. Conclusion: The management of pediatric bipolar disorder often requires multiple medications. For the treatment of mania/mixed states, clinicians prescribed second-generation antipsychotics more frequently than mood stabilizers, especially in the context of monotherapy. Co-morbidity was a frequent problem with moderate success obtained with combined pharmacotherapy approaches. Further psychosocial strategies to augment pharmacotherapy may improve outcome while reducing the medication burden in pediatric bipolar disorder.",
author = "Potter, {Mona P.} and Liu, {Howard Y} and Monuteaux, {Michael C.} and Henderson, {Carly S.} and Janet Wozniak and Wilens, {Timothy E.} and Joseph Biederman",
year = "2009",
month = "10",
day = "1",
doi = "10.1089/cap.2008.0142",
language = "English (US)",
volume = "19",
pages = "529--538",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic

AU - Potter, Mona P.

AU - Liu, Howard Y

AU - Monuteaux, Michael C.

AU - Henderson, Carly S.

AU - Wozniak, Janet

AU - Wilens, Timothy E.

AU - Biederman, Joseph

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Objective: The aim of this study was to describe prescribing practices in the treatment of pediatric bipolar disorder in a university practice setting. Method: A retrospective chart review was performed on 53 youths diagnosed using Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), criteria with bipolar spectrum disorder under the active care of child psychiatrists practicing in a pediatric psychopharmacology specialty clinic. Current medications, doses, and related adverse events were recorded. Clinicians were asked to provide a target disorder (bipolar mania/mixed state, depression, attention deficit hyperactivity disorder [ADHD], or anxiety) for each medication to the best of their ability. The Clinical Global Impressions-Severity (CGI-S) scale was used to measure severity of each disorder before treatment and the Clinical Global Impressions-Improvement (CGI-I) was used to quantify the magnitude of improvement with treatment. Meaningful improvement of the disorder was defined by CGI-I score of 1 or 2. Results: The mean number of psychotropic medications per patient was 3.0± 1.6. A total of 68% of patients were treated for co-morbid disorders; 23% of patients were treated with monotherapy, primarily with second-generation antipsychotics. Mania improved in 80% of cases, mixed state improved in 57% of cases, ADHD improved in 56% of cases, anxiety improved in 61% of cases, and depression improved in 90% of cases. Conclusion: The management of pediatric bipolar disorder often requires multiple medications. For the treatment of mania/mixed states, clinicians prescribed second-generation antipsychotics more frequently than mood stabilizers, especially in the context of monotherapy. Co-morbidity was a frequent problem with moderate success obtained with combined pharmacotherapy approaches. Further psychosocial strategies to augment pharmacotherapy may improve outcome while reducing the medication burden in pediatric bipolar disorder.

AB - Objective: The aim of this study was to describe prescribing practices in the treatment of pediatric bipolar disorder in a university practice setting. Method: A retrospective chart review was performed on 53 youths diagnosed using Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), criteria with bipolar spectrum disorder under the active care of child psychiatrists practicing in a pediatric psychopharmacology specialty clinic. Current medications, doses, and related adverse events were recorded. Clinicians were asked to provide a target disorder (bipolar mania/mixed state, depression, attention deficit hyperactivity disorder [ADHD], or anxiety) for each medication to the best of their ability. The Clinical Global Impressions-Severity (CGI-S) scale was used to measure severity of each disorder before treatment and the Clinical Global Impressions-Improvement (CGI-I) was used to quantify the magnitude of improvement with treatment. Meaningful improvement of the disorder was defined by CGI-I score of 1 or 2. Results: The mean number of psychotropic medications per patient was 3.0± 1.6. A total of 68% of patients were treated for co-morbid disorders; 23% of patients were treated with monotherapy, primarily with second-generation antipsychotics. Mania improved in 80% of cases, mixed state improved in 57% of cases, ADHD improved in 56% of cases, anxiety improved in 61% of cases, and depression improved in 90% of cases. Conclusion: The management of pediatric bipolar disorder often requires multiple medications. For the treatment of mania/mixed states, clinicians prescribed second-generation antipsychotics more frequently than mood stabilizers, especially in the context of monotherapy. Co-morbidity was a frequent problem with moderate success obtained with combined pharmacotherapy approaches. Further psychosocial strategies to augment pharmacotherapy may improve outcome while reducing the medication burden in pediatric bipolar disorder.

UR - http://www.scopus.com/inward/record.url?scp=70449397332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449397332&partnerID=8YFLogxK

U2 - 10.1089/cap.2008.0142

DO - 10.1089/cap.2008.0142

M3 - Article

VL - 19

SP - 529

EP - 538

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 5

ER -